- Home
- FHTX vs XRN Comparison
FHTX vs XRN Comparison
Compare FHTX & XRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FHTX | XRN |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 419.9M | 481.5M |
| IPO Year | 2020 | 2011 |
Fundamental Metrics
Financial Performance| Metric | FHTX | XRN |
|---|---|---|
| Price | $6.22 | $36.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $11.50 | N/A |
| AVG Volume (30 Days) | ★ 299.4K | 81.5K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 8.56% |
| EPS Growth | ★ 25.32 | N/A |
| EPS | N/A | ★ 4.73 |
| Revenue | $30,909,000.00 | ★ $148,208,000.00 |
| Revenue This Year | $8.89 | $4.50 |
| Revenue Next Year | $20.13 | $3.83 |
| P/E Ratio | ★ N/A | $7.89 |
| Revenue Growth | ★ 36.75 | 6.79 |
| 52 Week Low | $3.27 | $29.05 |
| 52 Week High | $7.61 | $38.65 |
Technical Indicators
Market Signals| Indicator | FHTX | XRN |
|---|---|---|
| Relative Strength Index (RSI) | 51.05 | 51.10 |
| Support Level | $4.21 | $34.64 |
| Resistance Level | $6.76 | $38.11 |
| Average True Range (ATR) | 0.53 | 0.89 |
| MACD | -0.04 | 0.12 |
| Stochastic Oscillator | 12.95 | 64.79 |
Price Performance
Historical ComparisonAbout FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
About XRN Chiron Real Estate Inc. Common Stock
Chiron Real Estate Inc is a real estate investment trust focused on investing and actively managing critical healthcare infrastructure. Its portfolio includes Spectrum-Dumfries, Slippery Rock MOB, Gainesville Eye Center, Aurora Sports Health, and many Others. Geographically, the company has it's concentration in a small number of states, including Texas, Florida, Ohio, Arizona, Pennsylvania, and Illinois.